[HTML][HTML] Hepatocellular carcinoma: The role of immunotherapy and transplantation in the era of transplant oncology
S Alghamdi, W Al-Hamoudi - Cancers, 2023 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is a common cause of cancer-related
deaths worldwide. During the early stages of the disease, HCC can be treated with surgery …
deaths worldwide. During the early stages of the disease, HCC can be treated with surgery …
Downstaging Hepatocellular Carcinoma before Transplantation: Role of Immunotherapy Versus Locoregional Approaches
J Lindemann, J Yu, MBM Doyle - Surgical Oncology Clinics, 2024 - surgonc.theclinics.com
Primary liver cancer was the third most common cause of death due to cancer worldwide in
2020, and it is estimated that more than 1 million people will develop liver cancer annually …
2020, and it is estimated that more than 1 million people will develop liver cancer annually …
[HTML][HTML] Indication of Liver Transplant for HCC: Current Status and Future Directions
JK Horwitz, VG Agopian - Current Hepatology Reports, 2024 - Springer
Abstract Purpose of Review Liver transplantation remains the gold-standard treatment for
cirrhotic patients with early stage, surgically unresectable hepatocellular carcinoma (HCC) …
cirrhotic patients with early stage, surgically unresectable hepatocellular carcinoma (HCC) …
[HTML][HTML] Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve …
J Kwon, J Kim, J Rhu, GS Choi, JW Joh - Annals of Liver Transplantation, 2023 - e-alt.org
Background: Systemic treatment options for hepatocellular carcinoma (HCC) after liver
transplantation (LT) are limited in patients in whom sorafenib treatment was failed. The …
transplantation (LT) are limited in patients in whom sorafenib treatment was failed. The …
[引用][C] Liver transplantation as an alternative treatment for primary hepatobiliary and secondary liver tumors: Competitors or allies?
J Lerut - Hepatobiliary & Pancreatic Diseases International, 2023 - Elsevier